These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 25178079)
41. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997 [TBL] [Abstract][Full Text] [Related]
42. Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. Giles JT; Danielides S; Szklo M; Post WS; Blumenthal RS; Petri M; Schreiner PJ; Budoff M; Detrano R; Bathon JM Arthritis Rheumatol; 2015 Mar; 67(3):626-36. PubMed ID: 25504899 [TBL] [Abstract][Full Text] [Related]
43. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265 [TBL] [Abstract][Full Text] [Related]
44. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study. Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840 [TBL] [Abstract][Full Text] [Related]
45. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin. Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M; Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for coronary, aortic arch and carotid calcification; The Rotterdam Study. Odink AE; van der Lugt A; Hofman A; Hunink MG; Breteler MM; Krestin GP; Witteman JC J Hum Hypertens; 2010 Feb; 24(2):86-92. PubMed ID: 19494836 [TBL] [Abstract][Full Text] [Related]
47. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM Arthritis Res Ther; 2006; 8(6):R186. PubMed ID: 17169159 [TBL] [Abstract][Full Text] [Related]
48. Rationale of decreasing low-density lipoprotein cholesterol below 70 mg/dL in patients with coronary artery disease: A retrospective virtual histology-intravascular ultrasound study. Seo YH; Seo DJ; Song IG; Kim KH; Kwon TG; Bae JH Cardiol J; 2018; 25(6):674-682. PubMed ID: 29341060 [TBL] [Abstract][Full Text] [Related]
49. Atheroma progression in hyporesponders to statin therapy. Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430 [TBL] [Abstract][Full Text] [Related]
50. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines. Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984 [TBL] [Abstract][Full Text] [Related]
52. Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study. Wahlin B; Meedt T; Jonsson F; Henein MY; Wållberg-Jonsson S Biomed Res Int; 2016; 2016():1261582. PubMed ID: 27648442 [TBL] [Abstract][Full Text] [Related]
53. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up. Tournadre A; Pereira B; Dubost JJ; Rincheval N; Rat AC; Combe B; Soubrier M Clin Exp Rheumatol; 2017; 35(2):296-302. PubMed ID: 28079508 [TBL] [Abstract][Full Text] [Related]
54. Search for an optimal atherogenic lipid risk profile: from the Framingham Study. Nam BH; Kannel WB; D'Agostino RB Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398 [TBL] [Abstract][Full Text] [Related]
55. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [TBL] [Abstract][Full Text] [Related]
56. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study. Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850 [TBL] [Abstract][Full Text] [Related]
57. A comparison of HDL and LDL cholesterol for prevalent coronary calcification. Allison MA; Wright CM Int J Cardiol; 2004 May; 95(1):55-60. PubMed ID: 15159039 [TBL] [Abstract][Full Text] [Related]
60. Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women. Nishino M; Malloy MJ; Naya-Vigne J; Russell J; Kane JP; Redberg RF J Am Coll Cardiol; 2000 Feb; 35(2):314-20. PubMed ID: 10676675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]